English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Background  Centrifugation is commonly used as a first step to enrich biomarkers from blood. Biomarkers are separated on the basis of density and/or diameter. However, the centrifugation protocol affects the yield and purity of biomarkers, for example, isolation of platelets results in co‐isolation with extracellular vesicles (EVs).    Objective  To assess the ability of rate zonal centrifugation (RZC) to separate platelets from co‐isolated EVs.    Methods  Using a linear Optiprep gradient, RZC was able to separate a mixture of beads with different diameters but similar density. Next, RZC was applied to samples containing both platelets and platelet‐derived EVs (n = 3). After RZC, all fractions were collected and stained with anti‐CD61‐Alexa 488 to measure the concentrations of platelets and platelet‐derived EVs by flow cytometry.    Results  We confirm that RZC separates polystyrene beads with diameters of 140 nm, 380 nm and 1,000 nm. Next, we show that the majority of platelets occur in fractions 8‐19, whereas the majority of platelet‐derived EVs are detectable in fractions 1‐7. Furthermore, each fraction contains a different diameter range of platelets, which suggests that separation is indeed diameter based.    Conclusion  RZC can partially separate platelets from EVs.

Rate zonal centrifugation can partially separate platelets from platelet‐derived vesicles